Importance of complete response for outcomes of pregnancy in patients with autoimmune hepatitis
- PMID: 36594353
- DOI: 10.1111/liv.15511
Importance of complete response for outcomes of pregnancy in patients with autoimmune hepatitis
Abstract
Background and aims: While some articles describe outcome of pregnancy in autoimmune hepatitis (AIH), there are less data evaluating influence of AIH control on maternal and perinatal outcomes. This study analysed outcomes of pregnancy and related possible risk factors in AIH.
Method: A retrospective multicentre cohort study on pregnancy in AIH was performed in 11 hospitals in the Netherlands. Maternal and neonatal outcomes were collected from records and completed by interview. Risk factors-including incomplete response, relapse and cirrhosis-for adverse outcomes were identified using logistic regression analysis.
Results: Ninety-seven pregnancies in 50 women resulted in 70 deliveries (72%) with a live birth rate of 98.5%. AIH relapse occurred in 6% during pregnancy, and in 27% of post-partum episodes. Absence of complete biochemical response at conception was identified as risk factor for the occurrence of gestational and post-partum relapses. Relapse of AIH in the year before conception was a risk factor for the occurrence of both gestational relapses and post-partum relapses. No complete biochemical response increased the risk for hypertensive disorders during pregnancy and intrahepatic cholestasis of pregnancy (ICP). Cirrhosis was found to be a risk factor for miscarriages, but not for other outcomes.
Conclusion: Pregnancy in AIH is related to an increased incidence of maternal and fetal/neonatal complications; in most cases, outcome is good. Incomplete biochemical response at conception or relapse in the year before conception are risk factors for gestational and post-partum relapses, for hypertensive disorders and for ICP. Cirrhosis was a risk factor for miscarriages.
Keywords: autoimmune hepatitis; outcome; pregnancy; remission.
© 2023 The Authors. Liver International published by John Wiley & Sons Ltd.
References
REFERENCES
-
- Alvarez F, Berg PA, Bianchi FB, et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31(5):929-938. doi:10.1016/S0168-8278(99)80297-9
-
- Manns MP, Czaja AJ, Gorham JD, et al. Diagnosis and management of autoimmune hepatitis. Hepatology. 2010;51(6):2193-2213. doi:10.1002/hep.23584
-
- Van Gerven NMF, Verwer BJ, Witte BI, et al. Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands. Scand J Gastroenterol. 2014;49(10):1245-1254. doi:10.3109/00365521.2014.946083
-
- Bozward AG, Wootton GE, Podstawka O, Oo YH. Autoimmune hepatitis: tolerogenic immunological state during pregnancy and immune escape in post-partum. Front Immunol. 2020;11(September):1-10. doi:10.3389/fimmu.2020.591380
-
- Biewenga M, Verhelst X, Baven-Pronk M, et al. Aminotransferases during treatment predict long-term survival in patients with autoimmune hepatitis type 1: a landmark analysis. Clin Gastroenterol Hepatol. 2021;20:1776-1783.e4. doi:10.1016/j.cgh.2021.05.024
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical